RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alliance Pharma Stock

Alliance Pharma Revenue 2024

Alliance Pharma Revenue

195.03 M GBP

Ticker

APH.L

ISIN

GB0031030819

WKN

913253

In 2024, Alliance Pharma's sales reached 195.03 M GBP, a 7.94% difference from the 180.68 M GBP sales recorded in the previous year.

The Alliance Pharma Revenue history

YEARREVENUE (undefined GBP)GROSS MARGIN (%)
2029e258.6940,60
2028e252.4141,61
2027e236.9544,32
2026e214.8548,88
2025e208.3450,41
2024e195.0353,85
2023180.6858,12
2022167.4260,74
2021163.2167,06
2020129.863,80
2019135.6463,46
2018118.2161,46
2017101.6458,19
201697.4956,26
201548.3459,43
201443.5457,52
201345.560,22
201244.955,90
20114653,26
201049.960,92
200931.258,01
200821.850,92
200718.248,90
200617.353,18
200512.354,47
200411.852,54

Alliance Pharma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Alliance Pharma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Alliance Pharma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Alliance Pharma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Alliance Pharma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Alliance Pharma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Alliance Pharma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Alliance Pharma’s growth potential.

Alliance Pharma Revenue, EBIT and net profit per share

DateAlliance Pharma RevenueAlliance Pharma EBITAlliance Pharma Net Income
2029e258.69 M undefined0 undefined0 undefined
2028e252.41 M undefined62.21 M undefined0 undefined
2027e236.95 M undefined53.23 M undefined34.8 M undefined
2026e214.85 M undefined44.69 M undefined31.57 M undefined
2025e208.34 M undefined42.64 M undefined28.18 M undefined
2024e195.03 M undefined40.83 M undefined24.66 M undefined
2023180.68 M undefined34.66 M undefined-33.14 M undefined
2022167.42 M undefined28.43 M undefined-21.21 M undefined
2021163.21 M undefined30.57 M undefined7.32 M undefined
2020129.8 M undefined29.67 M undefined8.03 M undefined
2019135.64 M undefined37.45 M undefined25.01 M undefined
2018118.21 M undefined28.92 M undefined18.36 M undefined
2017101.64 M undefined25.8 M undefined28.83 M undefined
201697.49 M undefined25.31 M undefined18.09 M undefined
201548.34 M undefined12.28 M undefined12.69 M undefined
201443.54 M undefined11.47 M undefined8.39 M undefined
201345.5 M undefined13.4 M undefined9.6 M undefined
201244.9 M undefined12.3 M undefined8.7 M undefined
201146 M undefined12.3 M undefined8.6 M undefined
201049.9 M undefined18.7 M undefined9 M undefined
200931.2 M undefined11.2 M undefined4.1 M undefined
200821.8 M undefined6.4 M undefined2.5 M undefined
200718.2 M undefined3.6 M undefined-3 M undefined
200617.3 M undefined2.6 M undefined500,000 undefined
200512.3 M undefined2 M undefined700,000 undefined
200411.8 M undefined2.3 M undefined400,000 undefined

Alliance Pharma stock margins

The Alliance Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alliance Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alliance Pharma.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Alliance Pharma's sales revenue. A higher gross margin percentage indicates that the Alliance Pharma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Alliance Pharma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Alliance Pharma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Alliance Pharma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Alliance Pharma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Alliance Pharma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Alliance Pharma Margin History

Alliance Pharma Gross marginAlliance Pharma Profit marginAlliance Pharma EBIT marginAlliance Pharma Profit margin
2029e58.12 %0 %0 %
2028e58.12 %24.65 %0 %
2027e58.12 %22.46 %14.69 %
2026e58.12 %20.8 %14.69 %
2025e58.12 %20.46 %13.53 %
2024e58.12 %20.94 %12.65 %
202358.12 %19.18 %-18.34 %
202260.74 %16.98 %-12.67 %
202167.06 %18.73 %4.48 %
202063.8 %22.86 %6.18 %
201963.46 %27.61 %18.44 %
201861.46 %24.47 %15.53 %
201758.19 %25.38 %28.36 %
201656.26 %25.96 %18.56 %
201559.43 %25.41 %26.25 %
201457.52 %26.36 %19.26 %
201360.22 %29.45 %21.1 %
201255.9 %27.39 %19.38 %
201153.26 %26.74 %18.7 %
201060.92 %37.47 %18.04 %
200958.01 %35.9 %13.14 %
200850.92 %29.36 %11.47 %
200748.9 %19.78 %-16.48 %
200653.18 %15.03 %2.89 %
200554.47 %16.26 %5.69 %
200452.54 %19.49 %3.39 %

Alliance Pharma Aktienanalyse

What does Alliance Pharma do?

Alliance Pharma PLC is a globally operating pharmaceutical company specializing in the marketing and development of pharmaceutical products. The company is headquartered in the United Kingdom and was founded in 1996. Alliance Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Alliance Pharma's Sales Figures

The sales figures of Alliance Pharma originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Alliance Pharma’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Alliance Pharma's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Alliance Pharma’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Alliance Pharma stock

How much revenue did Alliance Pharma generate this year?

Alliance Pharma has achieved a revenue of 195.03 M GBP this year.

How much was the turnover of the company Alliance Pharma compared to the previous year?

The revenue of Alliance Pharma has increased by 7.94% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Alliance Pharma?

The revenue of Alliance Pharma is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Alliance Pharma measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Alliance Pharma so important for investors?

The revenue of Alliance Pharma is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Alliance Pharma pay?

Over the past 12 months, Alliance Pharma paid a dividend of 0.02 GBP . This corresponds to a dividend yield of about 5.54 %. For the coming 12 months, Alliance Pharma is expected to pay a dividend of 0.02 GBP.

What is the dividend yield of Alliance Pharma?

The current dividend yield of Alliance Pharma is 5.54 %.

When does Alliance Pharma pay dividends?

Alliance Pharma pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Alliance Pharma?

Alliance Pharma paid dividends every year for the past 0 years.

What is the dividend of Alliance Pharma?

For the upcoming 12 months, dividends amounting to 0.02 GBP are expected. This corresponds to a dividend yield of 5.59 %.

In which sector is Alliance Pharma located?

Alliance Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alliance Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alliance Pharma from 7/18/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 6/22/2023.

When did Alliance Pharma pay the last dividend?

The last dividend was paid out on 7/18/2023.

What was the dividend of Alliance Pharma in the year 2023?

In the year 2023, Alliance Pharma distributed 0.017 GBP as dividends.

In which currency does Alliance Pharma pay out the dividend?

The dividends of Alliance Pharma are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Alliance Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Alliance Pharma

Our stock analysis for Alliance Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alliance Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.